Specifications
- Supplier
- MedChemExpress
- Catalog No
- HY-100009
- Product Name
- Ufenamate
- Description
- Ufenamate (Flufenamic acid butyl ester) is an anthranilic acid-based anti-inflammatory drug that can be used in the study of skin diseases such as acute and chronic eczema, contact dermatitis, diaper dermatitis, miliary rashes and atopic dermatitis. Ufenamate has a certain photoprotective effect, reduces the degree of skin erythema and swelling in the photoaging model, downregulates the expression level of COX-2 and can promote the healing of mouse skull defects by secreting BMP2[1][2][3][4].
- Size
- 50 mg
- Datasheet
- http://file.medchemexpress.com/batch_PDF/HY-100009/Ufenamate-DataSheet-MedChemExpress.pdf
- Msds
- http://file.medchemexpress.com/batch_PDF/HY-100009/Ufenamate-SDS-MedChemExpress.pdf
- Application
- COVID-19-immunoregulation
- Cas No
- 67330-25-0
- Isotype
- COX-2
- Target Immunogen
- COX;Prostaglandin Receptor
- Storage
- -20°C, 3 years; 4°C, 2 years (Powder)
- Shipping
- Room Temperature
- Product Type
- Reference compound
- Research Area
- Inflammation/Immunology
- Format
- C18H18F3NO2
- Synonym
- Flufenamic acid butyl ester; Butyl flufenamate
Documentation
No documentation found.
Publications
No publications found.
